- 中文名
- (2R,3S)-N1-((S)-3,3-二甲基-1-(甲基氨基)-1-氧代丁烷-2-基)-N4,3-二羟基-2-异丁基琥珀酰胺
- 英文名
- (2R,3S)-N1-((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4,3-dihydroxy-2-isobutylsuccinamide
- CAS号
- 154039-60-8
- 分子式
- C15H29N3O5
- 分子量
- 331.41
- 中文别名
- Marimastat
- 英文别名
- Marimastat; BB-2516; BB 2516; BB2516; D5EQV23TDS; NSC-719333; GI5712; KB-R 8898; TA2516; GI-5712; TA-2516; (2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoxy)propyl)carboyl)-2-hydroxy-5-methylhexanohydroxamic acid; CHEBI:50662; DTXSID20165524; NSC689451; NSC719333; Marimistat; (2S,3R)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N',2-dihydroxy-3-(2-methylpropyl)butanediamide; marimastatum; (2S,3R)-N-((1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl)-N',2-dihydroxy-3-(2-methylpropyl)butanediamide; RefChem:810621; DTXCID3088015; (2S,3R)-3-((S)-(2,2-Dimethyl-1-(methylcarbamoyl) propyl)carbamoyl)-2-hydroxy-5-methylhexanohydroxamic acid; Marimastat (BB-2516); (2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide; (2R,3S)-N1-((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4,3-dihydroxy-2-isobutylsuccinamide; MFCD00866242; BB2516; TA2516; CHEMBL279785; Marimastat [USAN]; TA 2516; (2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl)carbamoyl)-2-hydroxy-5-methylhexanohydroxamic acid; (2S,3R)-N(4)-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N(1),2-dihydroxy-3-(2-methylpropyl)butanediamide; (2R)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxo-ethyl]-4-methyl-pentanamide; (2s,3r)-N~4~-[(1s)-2,2-Dimethyl-1-(Methylcarbamoyl)propyl]-N~1~,2-Dihydroxy-3-(2-Methylpropyl)butanediamide; Butanediamide, N4-((1S)-2,2-dimethyl-1-((methylamino)carbonyl)propyl)-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-; Butanediamide, N4-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-; SMR002530328; Marimastat (USAN/INN); UNII-D5EQV23TDS; Marimastat [USAN:INN:BAN]; (2S,3R)-3-[[(1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl]carbamoyl]-2-hydroxy-5-methylhexanohydroxamic acid; Butaneamide,2-dimethyl-1-[(methylamino)carbonyl]propyl]- N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-; 3hy7; MARIMASTAT [MI]; MARIMASTAT [INN]; D03795; MARIMASTAT [MART.]; MARIMASTAT [WHO-DD]; SCHEMBL34033; MLS003899230; MLS006010669; cid_119031; GTPL5220; orb1300377; Marimastat, >=98% (HPLC); EX-A643; GLXC-06760; BDBM50063917; s7156; AKOS024457206; CCG-267821; CS-3456; DB00786; GI 5712; NSC 719333; NSC-689451; (2S,3R)-N'-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N,2-dihydroxy-3-(2-methylpropyl)butanediamide; (2S,3R)-N4-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamide; AC-35828; AS-57129; Butanediamide, N(sup 4)-(2,2-dimethyl-1-((methylamino)carbonyl)propyl)-N(sup 1),2-dihydroxy-3-(2-methylpropyl)-, (2S-(N(sup 4)(R*),2R*,3S*))-; Butanediamide, N4-(2,2-dimethyl-1-((methylamino)carbonyl)propyl)-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S-(N4(R*),2R*,3S*))-; FM161188; HY-12169; NS00068619; Q6763659; BRD-K21396683-001-04-8; (2S,3R)-N~4~-[(2S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N~1~,2-dihydroxy-3-(2-methylpropyl)butanediamide
